All News #Library
Biotech
NetraMark and AlgoTx Partner for ATX01 Clinical Trial Design
28 Jul 2025 //
GLOBENEWSWIRE
AlgoTx Reports Ph 2 ACT Trial Results For ATX01 In CIPN
18 Feb 2025 //
GLOBENEWSWIRE
AlgoTx Completes Phase II Trial Of ATX01 In Neuropathy
23 Sep 2024 //
GLOBENEWSWIRE

Market Place
Sourcing Support